Eli Lilly’s Oral GLP-1 Approved, SpaceX Confidentially Files for IPO, Potential Activist Targets 4/1/26
About this episode
Breaking this hour… Eli Lilly’s oral weight-loss pill approved by the FDA. What the company’s CEO told CNBC about the growth story. Then new reports say SpaceX has confidentially filed for an IPO. Plus, which companies could be the next target of an activist investor? Barclays with a new report looking at just that.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time CNBC’s “Money Movers” publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from CNBC’s “Money Movers”
Bridgewater Founder Ray Dalio, Setup for Tech Earnings, Calls for DHS Funding Gr...
CNBC’s “Money Movers”
DOJ Drops Probe into Fed Chair Powell, OpenAI CFO Sarah Friar, CrowdStrike CEO o...
CNBC’s “Money Movers”
Software Tumbles, Chips Jump, Data Center Opportunity with CBRE CEO, Pinnacle Fi...
CNBC’s “Money Movers”
GE Vernona & AI Demand, Philip Morris CEO, SpaceX’s AI Strategy 4/22/26
CNBC’s “Money Movers”